Publishing research using ab133534? Please let us know so that we can cite the reference in this datasheet.

ab133534 has been referenced in 14 publications.

  • Zhong Q  et al. Cyclin D1 silencing impairs DNA double strand break repair, sensitizes BRCA1 wildtype ovarian cancer cells to olaparib. Gynecol Oncol 152:157-165 (2019). PubMed: 30414739
  • Luo J  et al. MicroRNA-146a-5p Enhances Radiosensitivity in Hepatocellular Carcinoma through Replication Protein A3 Induced Activation of the DNA Repair Pathway. Am J Physiol Cell Physiol N/A:N/A (2018). PubMed: 30462539
  • Tong L  et al. RDM1 plays an oncogenic role in human lung adenocarcinoma cells. Sci Rep 8:11525 (2018). PubMed: 30069034
  • Guo X  et al. HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair. J Exp Clin Cancer Res 37:205 (2018). PubMed: 30157958
  • Johnson TI  et al. Fumarate hydratase loss promotes mitotic entry in the presence of DNA damage after ionising radiation. Cell Death Dis 9:913 (2018). PubMed: 30190474
  • Gong H  et al. p73 coordinates with ?133p53 to promote DNA double-strand break repair. Cell Death Differ N/A:N/A (2018). PubMed: 29511339
  • Haas KT  et al. Single-molecule localization microscopy reveals molecular transactions during RAD51 filament assembly at cellular DNA damage sites. Nucleic Acids Res 46:2398-2416 (2018). PubMed: 29309696
  • Liu JC  et al. Di (2-ethylhexyl) phthalate exposure impairs meiotic progression and DNA damage repair in fetal mouse oocytes in vitro. Cell Death Dis 8:e2966 (2017). PubMed: 28771232
  • Mackay DR  et al. Nup153 and Nup50 promote recruitment of 53BP1 to DNA repair foci by antagonizing BRCA1-dependent events. J Cell Sci 130:3347-3359 (2017). PubMed: 28751496
  • Jones SE  et al. ATR Is a Therapeutic Target in Synovial Sarcoma. Cancer Res 77:7014-7026 (2017). PubMed: 29038346
  • Kondrashova O  et al. Secondary Somatic Mutations RestoringRAD51CandRAD51DAssociated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma. Cancer Discov 7:984-998 (2017). PubMed: 28588062
  • Gong L  et al. p53 isoform ?133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming. Sci Rep 6:37281 (2016). PubMed: 27874035
  • Boysen G  et al. SPOP mutation leads to genomic instability in prostate cancer. Elife 4:N/A (2015). WB . PubMed: 26374986
  • Shen Y  et al. BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency. Clin Cancer Res 19:5003-15 (2013). ICC/IF . PubMed: 23881923

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up